For Melanotan II specifically, commonly reported concerns include nausea, flushing, appetite changes, fatigue , and skin changes notably darkening of freckles or moles , which can complicate skin monitoring
Obesity specialists routinely see patients respond differently to GLP-1 drugs, and some appear to achieve meaningful weight loss on lower doses than others
Noted side effects of GLP-1 receptor agonists include: nausea, vomiting, constipation, diarrhea, or abdominal pain that can subside with continued use
Always prioritize guidance from licensed professionals when navigating these choices
Some insurers will cover semaglutide if obesity is diagnosed or if related health conditions (like diabetes or heart disease) are present